Comment from Moffitt Cancer Center

Summary: Moffitt Cancer Center, a National Cancer Institute-designated Comprehensive Cancer Center, expresses strong support for the draft guidance on New Approach Methodologies (NAMs) in drug development. They argue that the guidance provides a necessary, scientifically grounded validation framework that will accelerate the translation of human-relevant science into safe and effective therapies.